3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Leukoplakia: new trials by email Literature Review of Leukoplakia trials Research Report on Leukoplakia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fenretinide Mucoadhesive Patch: Evaluation of Oral Cancer Prevention Efficacy in Adults With Premalignant Oral Lesions. Mucoadhesive fenretinide-releasing system (FMS) - Oral Leukoplakia, Oral Dysplasia | Phase 1 | Completed | Ohio State University Comprehensive Cancer Center | 7 | 2025-10-14 | 2026-09-25 |
| Aspirin Mouthwash in Treating Patients With Oral Leukoplakia acetylsalicylic acid, gene expression analysis, protein expression analysis - Precancerous Condition | Phase 1 | Completed | Institute of Head and Neck Studies and Education, United Kingdom | 40 | 2010-02-01 | 2013-08-12 |
| Treatment of Oral Premalignant Lesions With 5-ALA PDT PDL-585, ScleroPLUS laser, 5-Aminolevulinic Acid (Levulan KerastickTM), Fluorescence Diagnosis Imaging - Leukoplakia, Erythroplakia | Phase 1 / Phase 2 | Completed | University of Arkansas | 29 | 2007-01-01 | 2015-03-24 |
Leukoplakia, Oral (2) · Erythroplasia (1) · Precancerous Conditions (1)
Neoplasms (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Head and Neck Neoplasms (2) · Mouth Diseases (2) · Mouth Neoplasms (2) · Neoplasms by Site (2) · Precancerous Conditions (2) · Stomatognathic Diseases (2)
Aminolevulinic Acid (1) · Aspirin (1) · Biopsy (1) · Gene Expression Profiling (1)
Institute of Head and Neck Studies and Education, United Kingdom (1) · Ohio State University Comprehensive Cancer Center (1) · University of Arkansas (1)
United States (2) · United Kingdom (1)
Gal Shafirstein, PhD (1) · Hisham Mehanna, MD (1) · Susan R. Mallery, DDS, PhD (1)
R01CA227273 (1)